Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stellar Biotechnologies, Inc V.KLH



TSXV:KLH - Post by User

Comment by invertedhammeron Sep 12, 2015 2:06am
183 Views
Post# 24098374

RE:RE:RE:RE:RE:The reason share consolidations often don't work....

RE:RE:RE:RE:RE:The reason share consolidations often don't work....Yes, I believe you're right, waitingstill. Stellar has a farming and production facility in operation already. However, from what I understand, Stellar, together with Ostiones Guerrero, will build a new facility just outside San Quintin, which will be conveniently located to where the limpets are captured. Apparently, Ostiones Guerrero is licensed to pull 12 metric tons of giant keyhole limpets annually from the ocean. The limpets will be transported to the new facility where they will be farmed. I'm not 100% on this but I think that because the molecule is being used for medical reasons they must have a more controlled facility for farming than what the ocean provides. As well, they say it could take a few years before there is sufficient evidence to prove that the derived protein consistently meets medical standards.

ledrog: I think the fact that they are sinking millions into this facility tells me that they are confident klh will become a standard carrier in immunotherapies. With the FDA fast tracking approval for KLH conjugate immunotherapies, Multiple clinical studies utilizing the molecule with great results, expanding supply agreements, the construction of a new, bigger and better facility, partnering with Ostiones Guerrero that has the rights to harvest keyhole limpets by the tons... I'd say this new facility, the RS and the naz won't be in vain. It looks promising, imo.

Also, Stellar doesn't seem to have problems raising cash for their business. Which is a good thing cause I'm thinking they will have to raise a bit more to fund this new venture with Ostiones Guerrero. I think they were wise to do the reverse split at this time. Won't know til it all plays out, though. GL
<< Previous
Bullboard Posts
Next >>